Kraig Biocraft Laboratories Inc (QB) (KBLB) 시세

****BREAKING NEWS****MASSIVE DILUTION IS IMMINENT****

A Standby Equity Purchase Agreement (SEPA) can offer public companies a convenient way to raise capital, but it comes with several potential downsides. Here are some of the cons:

1. Dilution of Existing Shares:
When shares are issued to the investor under a SEPA, it increases the total number of shares outstanding, which dilutes the ownership percentage of existing shareholders. This can lead to a decrease in the value of each share if the market does not absorb the new shares at a favorable price.

2. Share Price Impact:
The issuance of new shares might pressure the stock price downwards, especially if the market perceives the equity financing as a sign of financial weakness or if the shares are sold at a discount to the market price.

3. Cost and Fees:
SEPAs often come with various fees, such as commitment fees, structuring fees, and possibly legal and administrative costs. These can reduce the net proceeds the company receives from the equity sale.

4. Investor Control:
Depending on the terms, the investor might gain rights like board representation or veto rights over certain decisions, potentially impacting the company's strategic direction or autonomy.

5. Market Perception:
Frequent use of SEPAs might signal to the market that the company is in need of cash, potentially harming the company's reputation and investor confidence. This perception can make future capital raises more difficult or expensive.

6. Restrictive Covenants:
Agreements might include covenants that restrict the company's operational flexibility, such as limits on further debt, dividend payments, or additional equity issuance.

7. Timing and Control Over Funding:
While SEPAs provide flexibility in terms of when to issue shares, this can also be a disadvantage if the company needs funds urgently but market conditions are not favorable for share issuance.

8. Regulatory and Compliance Burden:
Public companies must adhere to securities regulations when issuing new shares, which involves compliance costs, disclosure requirements, and potentially triggering review by regulatory bodies.

9. Potential for Misalignment of Interests:
The investor might not always act in the best interest of all shareholders, especially if their investment strategy differs from long-term company growth or stability.

10. Complex Terms:
The terms of SEPAs can be complex, potentially leading to misunderstandings or disputes over execution, especially if market conditions change dramatically.

Each of these cons should be weighed against the benefits of a SEPA, considering the specific circumstances and strategic goals of the company. It's crucial for management to analyze whether the immediate access to capital justifies these potential drawbacks.

BIG NEWS $$

Kraig Labs Secures $10 Million SEPA to Support Spider Silk Production Growth and Commercialization

SELL! SELL! SELL!

Great news but I think my February date might be off a bit. "Developing new consumer products" means they haven't created a damn thing. I'm my opinion that's absolutely pathetic. They have enough to have produced a few products.

That being said, this does align with the 3 year timeline based on the recent stock options listed in the recent filing. A new product takes up to about 2 years to bring to market from start to finish.

We'll see, "soon."

https://www.sec.gov/Archives/edgar/data/1413119/000149315225003093/form8-k.htm

Thank you, 1987! GO KBLB! .

Thanks for this information, Money. GO KBLB!

Kraig Biocraft Laboratories Secures $10 Million SEPA to Support Spider Silk Production Growth and Commercialization

ANN ARBOR, Mich., – January 21, 2025 –Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), a leading developer of spider silk-based fibers, announces that it has secured $10 million in a standby equity purchase agreement ("SEPA") with YA II PN, Ltd. ("Yorkville"). This agreement will provide the Company with access to the working capital necessary to continue production expansion for its revolutionary recombinant spider silk fibers and materials.



Kraig Labs structured the SEPA to allow the Company to access capital over the next 36 months, when and how it determines best for the growth of spider silk production and end-market development. The Company is under no obligation to utilize this funding, has no minimum use requirements, and it does not impose any restrictions on the Company's operations. This agreement gives the Company the flexibility to access the capital necessary to bridge its transition to revenue generation.



“We have worked with Yorkville in the past and we are excited to renew and strengthen that relationship. This strategic financial relationship provides Kraig Labs with the flexibility to support the growth of spider silk commercialization," said Founder and CEO, Kim Thompson. "The SEPA provides access to significant growth capital, allowing us to focus on executing our vision for eco-friendly, cost-effective spider silk production. We will put this capital to work, building out our production capacity and spider silk inventory, developing new consumer products, and establishing partnerships with market channel sales partners."



For details about other recent advancements the Company has made, please see the Company's investor conference at www.kraiglabs.com/videos or on the Company's YouTube Channel https://www.youtube.com/@kraigbiocraftlaboratories2270.



To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news



The securities described herein have not been registered under the Securities Act of 1933, as amended, and may not be sold in the United States absent registration or an applicable exemption from the registration requirements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or other jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.



About Kraig Biocraft Laboratories, Inc.



Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk-based fiber technologies.



The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.



Cautionary Statement Regarding Forward Looking Information



Statements in this press release about the Company's future and expectations other than historical facts are "forward-looking statements." These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as "believes," "plans," "expects," "anticipates," "foresees," "estimated," "hopes," "if," "develops," "researching," "research," "pilot," "potential," "could" or other words or phrases of similar import. Forward looking statements include descriptions of the Company's business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.



Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

https://kraig-biocraft-laboratories.optin.com/newsletter/awlist5522866/MjYyNDA2MTI=/kraig-labs-secures-10-million-sepa-to-support-spider-silk-production-growth-and-commercialization.htm

Benefits of a Standby Equity Purchase Agreement for Companies
The benefits of a SEPA are numerous, particularly for growing companies that need flexibility in how they manage their capital raising. Here are some of the primary advantages:
1. Flexibility
A SEPA offers unmatched flexibility compared to other capital-raising methods. Companies can access funds as needed, rather than raising a lump sum upfront. This can be beneficial for companies with fluctuating cash flow needs.
2. Cost-Effective
By avoiding the need for a full-scale private placement, companies can save on costs associated with legal fees, underwriter fees, and other administrative expenses that typically accompany more traditional capital-raising mechanisms.
3. Minimal Shareholder Dilution
Since shares are sold over time and at more favorable prices, a SEPA can minimize the dilution that shareholders might face in a more traditional capital-raising scenario, where large numbers of shares are issued at once.
4. Favorable Market Timing
A SEPA gives companies the ability to time the issuance of shares to take advantage of favorable market conditions, helping them raise more capital per share sold.
5. No Debt Incurred
Unlike loans or bonds, SEPA capital does not add debt to the company’s balance sheet. This can help improve the company’s financial stability and make it more attractive to investors.

Oops, open mouth , insert foot.

Oops, no PR today....

HUGE NEWS, FZA! GO KBLB!

NEWS!!

ANN ARBOR, Mich., – January 21, 2025 –Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company” or “Kraig Labs”), a leading developer of spider silk-based fibers, announces that it has secured $10 million in a standby equity purchase agreement (“SEPA”) with YA II PN, Ltd. (“Yorkville”). This agreement will provide the Company with access to the working capital necessary to continue production expansion for its revolutionary recombinant spider silk fibers and materials.

Kraig Labs structured the SEPA to allow the Company to access capital over the next 36 months, when and how it determines best for the growth of spider silk production and end-market development. The Company is under no obligation to utilize this funding, has no minimum use requirements, and it does not impose any restrictions on the Company’s operations. This agreement gives the Company the flexibility to access the capital necessary to bridge its transition to revenue generation.

“We have worked with Yorkville in the past and we are excited to renew and strengthen that relationship. This strategic financial relationship provides Kraig Labs with the flexibility to support the growth of spider silk commercialization,” said Founder and CEO, Kim Thompson. “The SEPA provides access to significant growth capital, allowing us to focus on executing our vision for eco-friendly, cost-effective spider silk production. We will put this capital to work, building out our production capacity and spider silk inventory, developing new consumer products, and establishing partnerships with market channel sales partners.”

For details about other recent advancements the Company has made, please see the Company’s investor conference at www.kraiglabs.com/videos or on the Company’s YouTube Channel https://www.youtube.com/@kraigbiocraftlaboratories2270.

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news

The securities described herein have not been registered under the Securities Act of 1933, as amended, and may not be sold in the United States absent registration or an applicable exemption from the registration requirements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or other jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk-based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

Twice as much as they had announced back in Dec they were looking for. I see this as great news indeed as there should be nothing to stop them from aggressively ramping up now. Interesting times ahead.

Kraig Labs Secures $10 Million SEPA to Support Spider Silk Production Growth and Commercialization

News

Excellent post, EisMCA. You are spot on in every line. Anything less that ten dollars in a BO situation is an insult. GO KBLB!

The next batch of spinning cocoons should start by next week, and be done with the 3 days of spinning by end of January or first few days of February. I didn't expect any news until next week. Plus, the inauguration pretty much runs the new cycle this week so it would have buried any news from KBLB.

Looking forward to tonnage announcements, then contract announcements. I'd take a BO of nothing less than $10 pps. Spider Silk has way too many potential uses and markets to go for less than that.

KBLB is making what no others can.
Beyond Kong and Very Strong!
MCA

So sell your shares. You’ve certainly made it clear you’ve been played by the CEO. So your answer is to stay invested and continue to be played and just whine , moan , and groan about it for an eternity ?

Good old Kim Thompson back to playing his shareholders again.

...For about 50,000 of the publicly-traded companies! Go figure 🤔

"Everybody" could invest in those others producing sales. Oh wait, that's right, THERE ARE NO OTHERS!!! 🤣🤣🤣

Good old Kim Thompson back to playing his shareholders again. I wonder what the next PR is going to say.. I’m sure it’s something to do with the latest and greatest Mulberry leaf. Man, I tell you this guy is a piece of work.. everybody wants to see sales, unfortunately, you’re dealing with the turd of turds Kimberly, Thompson.

Oops, no PR today....

No news this week either?… Not liking the silent treatment again… I guess my patience has worn thin.

No news this week, from previous Pr’s, there seems to be some great material news Kim could be disclosing to shareholders. Another week into 2025 and No production news…. Go Figure….

RU praising yourself Mullet?

Great post. We should point it every week!!

the silkworms are a self-generating money machine that continually makes KBLB money

That deserves a repost!

How about an update on Cambodia?

In response to:

KRAIG BIOCRAFT LABORATORIES ANNOUNCES INTENTION TO DIVERSIFY AND EXPAND ITS PRODUCTION BASE

ANN ARBOR, Mich., – May 13, 2024 –Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company” or “Kraig Labs”), announces today that it is pursuing a possible business expansion into Cambodia to support the rapid growth and diversification of its recombinant spider silk production.

https://www.kraiglabs.com/kraig-biocraft-laboratories-announces-intention-to-diversify-and-expand-its-production-base/

KBLB is its own animal. Whether it finally gets let out of the cage this year or not is entirely up to Kim. But BAM-1 is ready to run wild. Open the gate.

I think the mention of that in the video was entirely unnecessary, but we know that has been a goal of his for years. I was just like “really” when he said it, because it wasn’t necessary and didn’t fit the overall narrative about their successes. Grow production. Make the metric tons. Get some actual sales. Then talk about uplist. Maybe Kim doesn’t believe the pps can organically grow above $4 pps without an uplist or a &@$/“@& reverse split, but I do. The focus needs to be on silk production and making a path to consistent silk production in successful end products. Everything takes care of itself if they do that. Because then the silkworms are a self-generating money machine that continually makes KBLB money. I don’t understand why everyone is so distracted by “uplist” when it does nothing for silk production or sales revenue. If he wants to take on an investor who is willing to back more 25-metric ton facilities in exchange for uplisting okay, but if not, I don’t wanna hear about uplisting until we’ve hit metric tonnage and actual sales of silk recognized on the books. Without production and sales it would be delisted just as fast as it uplisted. The roads are littered with trash. And KBLB has too great of an idea and product to not uplist when the time is right. Now ain’t the time unless somebody gonna back production.

"It’s all about production." It always has been!

I never said anything about up listing right now. If it happens, it will be on Kim's schedule, and I am fine with that. It was Kim who was talking about a "potential" up list in the web conference, so I do not see it as set in stone. If an investor is to survive holding KBLB, he/she must have patience. Nevertheless, things have advanced enough for some good news to be announced any day now. GO KBLB!

🤣🤣🤣 what a joke.

Just look at TSLA. That company is nothing compared to KBLB

Another day….

Another week….

Another big, fat, juicy, KBLB nothingburger….

with a side order of lies….

It’s all about production. EOD!

We don’t need to take a belly flop off a 100 foot tower into a shallow pool with no water. A successful uplist is not possible right now for KBLB without a reverse split which would change nothing fundamentally for the company. A reverse split and uplist does not increase silk production and it does not increase silk sales — those are two things KBLB must have before anybody should be talking about uplisting. Plus the pps needs to organically go up due to silk production and silk sales which might even render a reverse split not even necessary to uplist. That’s the best case scenario and would mean more staying power long term. Otherwise I could see it falling like BT and then the delisting notices start coming in the mail. There is a right way and a wrong way to do the uplist. The right way takes patience and discipline. Production and sales revenue will lead the way. That’s my opinion and I’m sticking to it.

Just look at TSLA. That company is nothing compared to KBLB
Nothing.
Of course, compared to KBLB.
nothing.

KBLB is 9.1 cents a share.  Not what I call priceless.

If Thompson did a 100-to-1 reverse split, the price of shares Monday would be around $10 each.  You shares would only be worth $40,000, but Bob could still have his $10/share buyout.

Simple...

The KBLB way.

Amen! If we up-list, the price will even go higher, much higher. Just look at TSLA. That company is nothing compared to KBLB and how their technology will change every aspect of life. KBLB IS PRICELESS!

If $10.00 it's the going price, that would be $4,000,000. in my pocket. ooooooooh do hope your right. from your lips to Gods ears. Amen

The web conference was meant for the entire world. If so we are in a sorry
state of affairs as evidently nobody listened.
Patrik

Exactly! This takes time. Also, do not rule out a BO. That web conference was meant for the entire world and especially for the business community. I would not be surprised to see a BO offer before any up list. This is what I have been praying for. May the Force be with us. After that web conference, I am convinced that ten dollars will be the floor. I would be shocked if a BO occurred, and the price was not at least ten bucks. That makes today's prices dirt cheap, yet folks are selling. Go figure, and GO KBLB!

Brings forward the age-old KBLB stone cold classic phrase..


"Maybe this month!"

Lmfao

bananarama, yes he will need tons of silk. 1.5 metric tons would not last long. 😊

Banana
You ave been telling everybody to load up since 2010. .09 and counting
patrik

Amen, Z-man! I think this is the quarter when it all starts going uphill, and it going to be huge. As Mojo said: "The pps will do what it will do until kim announces tonnage and customers, sales and revenue…and when that happens, NO ONE will be able to stop the rise in pps…"
GO KBLB!

Trainer.....I look at it this way. Kim has a lot on his plate right now. He will not begin releasing any of the good news until he is ready. That means until he feels comfortable with the amount of SS he has. The biggest mistake any OTC CEO can make is to up list without enough product. This is how many OTC companies go bankrupt. They just cannot meet the demand of their products, and they go bust.

Do you think there will be any demand for our SS? It will be through the roof, meaning Kim needs the silk and tons of it. So, I predicted this year would start off slowly. However, at some point, things will turn around very quickly, and when it does, I plan on being here. I have bought 200,000 more shares in the low nines over the last few weeks.

I tell everyone to load up now before the news begins. That is exactly what I have been doing. Sit back; be patient; enjoy the ride. IT IS COMING!
GO KBLB!